NCT00467935
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +24 more
- Locations
-
- Retina Research Center Slingerlands, New York, United States
Clinical trial condition
Glycogen Storage Disease Type II
Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.
105 public trials
19 recruiting studies
Glycogen Storage Disease Type II trial results
NCT00515398
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- University of Florida Gainesville, Florida, United States
- Washington University St Louis, Missouri, United States
- Center for Metabolic Disorders Lake Success, New York, United States
- Duke University Durham, North Carolina, United States
NCT00001331
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +24 more
- Locations
-
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States
Active, Not Recruiting
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
NCT06150820
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Emory Clinic Atlanta, Georgia, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- University of Michigan Ann Arbor, Michigan, United States
- Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States
Active, Not Recruiting
Early Check: Expanded Screening in Newborns
NCT03655223
- Conditions
- 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
- Locations
-
- RTI International Research Triangle Park, North Carolina, United States
Active, Not Recruiting
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
NCT04848779
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- Advanced Medical Genetics- Site Number : 8400002 Hawthorne, New York, United States
- Duke University Medical Center- Site Number : 8400004 Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center- Site Number : 8400001 Cincinnati, Ohio, United States
- Le Bonheur Children's Hospital- Site Number : 8400005 Memphis, Tennessee, United States
Active, Not Recruiting
Safety and Efficacy of Avalglucosidase Alfa in Patients With Non-classic Pompe Disease Aged ≥ 5 Years
NCT07652814
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
- Locations
-
- Erasmus MC Rotterdam, Netherlands
Active, Not Recruiting
Gene Transfer Study in Patients With Late Onset Pompe Disease
NCT04174105
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- University of California Irvine, Department of Neurology Orange, California, United States
- Stanford University Palo Alto, California, United States
- University of Utah, Division of Medical Genetics Salt Lake City, Utah, United States
- Newcastle Upon Tyne Hospitals Foundation Trust Clinical Research Facility Newcastle upon Tyne, United Kingdom
Active, Not Recruiting
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa
NCT04910776
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- Stanford Hospital- Site Number : 8400006 Stanford, California, United States
- Children's Hospitals and Clinics of Minnesota- Site Number : 8400008 Minneapolis, Minnesota, United States
- Advanced Medical Genetics- Site Number : 8400002 Hawthorne, New York, United States
- Duke University Medical Center- Site Number : 8400004 Durham, North Carolina, United States
Active, Not Recruiting
Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)
NCT05164055
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- Investigational Site Number : 2500004 Bordeaux, France
- Investigational Site Number : 2500005 Brest, France
- Investigational Site Number : 2500008 Clermont-Ferrand, France
- Investigational Site Number : 2500009 Lille, France
Related conditions
- Brain Diseases (105)
- Brain Diseases, Metabolic (105)
- Brain Diseases, Metabolic, Inborn (105)
- Carbohydrate Metabolism, Inborn Errors (105)
- Central Nervous System Diseases (105)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (105)
- Genetic Diseases, Inborn (105)
- Lysosomal Storage Diseases, Nervous System (105)